Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS - PubMed (original) (raw)
. 2014 Sep 3;83(5):1043-50.
doi: 10.1016/j.neuron.2014.07.041. Epub 2014 Aug 14.
Yongjie Zhang 2, Tania F Gendron 2, Peter O Bauer 2, Jeannie Chew 2, Wang-Yong Yang 1, Erik Fostvedt 1, Karen Jansen-West 2, Veronique V Belzil 2, Pamela Desaro 3, Amelia Johnston 3, Karen Overstreet 3, Seok-Yoon Oh 4, Peter K Todd 4, James D Berry 5, Merit E Cudkowicz 5, Bradley F Boeve 6, Dennis Dickson 2, Mary Kay Floeter 7, Bryan J Traynor 8, Claudia Morelli 9, Antonia Ratti [ 10](#full-view-affiliation-10 "Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Via Zucchi, 18, 20095 Cusano Milanino (Milan), Italy; Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Via Sforza, 35, 20122, Milan, Italy."), Vincenzo Silani [ 11](#full-view-affiliation-11 "Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Via Sforza, 35, 20122, Milan, Italy; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA."), Rosa Rademakers 2, Robert H Brown 12, Jeffrey D Rothstein 13, Kevin B Boylan 3, Leonard Petrucelli 14, Matthew D Disney 15
Affiliations
- PMID: 25132468
- PMCID: PMC4232217
- DOI: 10.1016/j.neuron.2014.07.041
Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS
Zhaoming Su et al. Neuron. 2014.
Erratum in
- Neuron. 2014 Oct 1;84(1):239
Abstract
A repeat expansion in C9ORF72 causes frontotemporal dementia and amyotrophic lateral sclerosis (c9FTD/ALS). RNA of the expanded repeat (r(GGGGCC)exp) forms nuclear foci or undergoes repeat-associated non-ATG (RAN) translation, producing "c9RAN proteins." Since neutralizing r(GGGGCC)exp could inhibit these potentially toxic events, we sought to identify small-molecule binders of r(GGGGCC)exp. Chemical and enzymatic probing of r(GGGGCC)8 indicate that it adopts a hairpin structure in equilibrium with a quadruplex structure. Using this model, bioactive small molecules targeting r(GGGGCC)exp were designed and found to significantly inhibit RAN translation and foci formation in cultured cells expressing r(GGGGCC)66 and neurons transdifferentiated from fibroblasts of repeat expansion carriers. Finally, we show that poly(GP) c9RAN proteins are specifically detected in c9ALS patient cerebrospinal fluid. Our findings highlight r(GGGGCC)exp-binding small molecules as a possible c9FTD/ALS therapeutic and suggest that c9RAN proteins could potentially serve as a pharmacodynamic biomarker to assess efficacy of therapies that target r(GGGGCC)exp.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
Fig. 1. Probing r(GGGGCC)n secondary structures
A) CD spectra of r(GGGGCC)4,6,8 and r(CGG)12 in the presence of various monovalent cations. B) Optical melting curves for r(GGGGCC)4,6,8 and r(CGG)12 monitored at 295 nm. RNA samples (4 μM) were folded prior to recording CD spectra (20°C) and optical melting curves. C) DMS mapping data (left), enzymatic mapping data (middle) and predicted hairpin structure of r(GGGGCC)8 using mapping restraints (right). DMS mapping lanes: 1, untreated RNA; 2, alkaline hydrolysis; 3, T1 digestion under denaturing conditions; 4, DMS modification in the presence of 185 mM Li+; 5, DMS modification in the presence of 185 mM K+. Enzymatic mapping lanes: 1, untreated RNA; 2, T1 digestion under denaturing conditions; 3, T1 digestion under native conditions; 4, V1 digestion in which base paired nucleotides are cleaved; 5, S1 digestion in which all single-stranded nucleotides are cleaved. D) 1D 1H NMR spectra of r(GGGGCC)8 in the presence of 100 mM K+ annealed at 37°C, 60°C, or 95°C. Blue circles are imino proton resonances from G residues present as base pairs and red squares are imino proton resonances from non-canonically paired G residues. E) Structures of lead compounds 1a, 2, and 3 that bind to r(GGGGCC)8. See also Figure S1.
Fig. 2. Small molecules targeting r(GGGGCC) inhibit RAN translation and foci formation in (GGGGCC)66-expressing cells
A) Structure of 1a-CA-biotin; the chlorambucil moiety (CA) forms a covalent bond with the cellular target once the small molecule is bound. Biotin is used to isolate biomolecule-small molecule adducts from cells. B) Normalized enrichment of r(GGGGCC)66 from biomolecules isolated with streptavidin beads as compared to 18S rRNA determined by qRT-PCR. Cells were treated with 1a-CA-biotin alone or with 1a, 2 or 3 (competitive profiling). In competitive profiling experiments, the unreactive compound inhibits reaction of the target with 1a-CA-biotin and thus the target is depleted in pull-down fractions. Data presented as mean±SD (n=2). C) Cells overexpressing 66 (GGGGCC) repeats (C9-66R), but not 2 (C9-2R) or 20 (C9-20R), express poly(GP) and poly(GA) proteins. Asterisks demark non-specific bands. D) Western blot and densitometry of poly(GP) and poly(GA) proteins in (GGGGCC)66-expressing cells treated with DMSO or compounds 1a, 2 or 3 (100 μM, 24 h). Data represents mean+SEM (n=3). E) RNA foci (red) are detected in the nucleus (Hoechst; blue) of C9-66R cells. F) Evaluation of the percentage of foci-positive cells by RNA FISH post-treatment. Data represents mean+SEM in 10 fields. G-H) Compound 1a decreases RAN translation of poly(GP) proteins from sense (GGGGCC)66 repeats in C9-66R cells (G), but does not influence levels of poly(GP) or poly(PR) proteins RAN translated from antisense (CCCCGG)66 repeats in C9-AS-66R cells (H), as assessed by GP and PR immunoassays. Data represents mean+SEM (n=3 or 4). I) The percentage of r(CCCCGG)-containing foci in C9-AS-66R cells is not affected by 1a. J) 1a decreases RAN translation of poly(G) in cells expressing (CGG)88 upstream of GFP. Data presented as mean+SEM (n=3). *P<0.05, **P<0.01, ***P<0.001, as assessed by One-way ANOVA followed by Dunnett's Multiple Comparison Test. ##P<0.01, as assessed by t-test. See also Figure S2.
Fig. 3. Small molecules targeting r(GGGGCC) inhibit RAN translation and foci formation in iNeurons with the C9ORF72 expansion
A) Immunofluorescence staining of fibroblasts transduced with non-silencing shRNA or shPTB1 for PTB1 and the neuronal marker, MAP2. Scale bar, 20 μm. B) PTB1 Western blot analysis of fibroblasts transduced or not with shPTB1. C) RNA foci accumulate in iNeurons with the C9ORF72 repeat expansion (C9ORF72+) but not in iNeurons lacking the expansion (C9ORF72-), as assessed by RNA FISH. Immunofluorescence staining with anti-GP or anti-PR illustrates the accumulation of c9RAN proteins specifically in C9ORF72+ iNeurons. Scale bars, 5 μm. D) Treatment of C9ORF72+ iNeurons with compound 1a (2 μM, 4 d) significantly decreased the percentage of cells with foci. For each iNeuron line, data reflects the average percentage of foci-positive cells+SEM in 3 separate fields. E-F) Compound 1a significantly decreased the percentage of cells with anti-GP, but not anti-PR, immunoreactive inclusions (magnification: 20x). For each line, data represent the average percentage of inclusion-positive cells+SEM counted in 9 wells of a 96-well plate. #P<0.05, ##P<0.01, as assessed by t test. See also Figure S3.
Fig. 4. Poly(GP) proteins are detected in c9ALS cerebrospinal fluid
A) Poly(GP) expression in CSF from 5 healthy individuals, 25 ALS patients negative for the C9ORF72 repeat expansion, and 14 c9ALS patients were assessed by GP immunoassay. Response values correspond to the intensity of emitted light from which the background response was subtracted. Dashed line represents the limit of detection [LoD=LoB+1.645(SDblank); where LoB (limit of blank)=meanblank+1.645(SDblank)]. **P<0.001, ***P<0.001 as assessed by one-way ANOVA followed by Tukey's Multiple Comparison Test. B) Schematic representation of the effect of r(GGGGCC)exp-targeting small molecules on foci formation and RAN translation, and the potential use of extracellular c9RAN proteins as a pharmacodynamic marker of treatment efficacy. See also Figure S4.
Similar articles
- Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.
Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, Cosio DM, van Blitterswijk M, Lee WC, Rademakers R, Boylan KB, Dickson DW, Petrucelli L. Gendron TF, et al. Acta Neuropathol. 2013 Dec;126(6):829-44. doi: 10.1007/s00401-013-1192-8. Epub 2013 Oct 16. Acta Neuropathol. 2013. PMID: 24129584 Free PMC article. - TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins.
Zamiri B, Reddy K, Macgregor RB Jr, Pearson CE. Zamiri B, et al. J Biol Chem. 2014 Feb 21;289(8):4653-9. doi: 10.1074/jbc.C113.502336. Epub 2013 Dec 26. J Biol Chem. 2014. PMID: 24371143 Free PMC article. - Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress.
Zhang YJ, Jansen-West K, Xu YF, Gendron TF, Bieniek KF, Lin WL, Sasaguri H, Caulfield T, Hubbard J, Daughrity L, Chew J, Belzil VV, Prudencio M, Stankowski JN, Castanedes-Casey M, Whitelaw E, Ash PE, DeTure M, Rademakers R, Boylan KB, Dickson DW, Petrucelli L. Zhang YJ, et al. Acta Neuropathol. 2014 Oct;128(4):505-24. doi: 10.1007/s00401-014-1336-5. Epub 2014 Aug 31. Acta Neuropathol. 2014. PMID: 25173361 Free PMC article. - Mechanisms of toxicity in C9FTLD/ALS.
Gendron TF, Belzil VV, Zhang YJ, Petrucelli L. Gendron TF, et al. Acta Neuropathol. 2014 Mar;127(3):359-76. doi: 10.1007/s00401-013-1237-z. Epub 2014 Jan 7. Acta Neuropathol. 2014. PMID: 24394885 Free PMC article. Review. - Advances in the Structure of GGGGCC Repeat RNA Sequence and Its Interaction with Small Molecules and Protein Partners.
Liu X, Zhao X, He J, Wang S, Shen X, Liu Q, Wang S. Liu X, et al. Molecules. 2023 Aug 1;28(15):5801. doi: 10.3390/molecules28155801. Molecules. 2023. PMID: 37570771 Free PMC article. Review.
Cited by
- A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV-C9ORF72 (G4C2)66 mouse model.
Thompson EG, Spead O, Akerman SC, Curcio C, Zaepfel BL, Kent ER, Philips T, Vijayakumar BG, Zacco A, Zhou W, Nagappan G, Rothstein JD. Thompson EG, et al. bioRxiv [Preprint]. 2024 Aug 27:2024.08.27.607409. doi: 10.1101/2024.08.27.607409. bioRxiv. 2024. PMID: 39253499 Free PMC article. Preprint. - Therapeutic targeting of RNA for neurological and neuromuscular disease.
Bubenik JL, Scotti MM, Swanson MS. Bubenik JL, et al. Genes Dev. 2024 Sep 19;38(15-16):698-717. doi: 10.1101/gad.351612.124. Genes Dev. 2024. PMID: 39142832 Review. - Zfp106 binds to G-quadruplex RNAs and inhibits RAN translation and formation of RNA foci caused by G4C2 repeats.
Celona B, Salomonsson SE, Wu H, Dang B, Kratochvil HT, Clelland CD, DeGrado WF, Black BL. Celona B, et al. Proc Natl Acad Sci U S A. 2024 Jul 30;121(31):e2220020121. doi: 10.1073/pnas.2220020121. Epub 2024 Jul 23. Proc Natl Acad Sci U S A. 2024. PMID: 39042693 - Crystal structure of a tetrameric RNA G-quadruplex formed by hexanucleotide repeat expansions of C9orf72 in ALS/FTD.
Geng Y, Liu C, Xu N, Suen MC, Miao H, Xie Y, Zhang B, Chen X, Song Y, Wang Z, Cai Q, Zhu G. Geng Y, et al. Nucleic Acids Res. 2024 Jul 22;52(13):7961-7970. doi: 10.1093/nar/gkae473. Nucleic Acids Res. 2024. PMID: 38860430 Free PMC article. - RNA tertiary structure and conformational dynamics revealed by BASH MaP.
Oleynikov M, Jaffrey SR. Oleynikov M, et al. bioRxiv [Preprint]. 2024 Aug 19:2024.04.11.589009. doi: 10.1101/2024.04.11.589009. bioRxiv. 2024. PMID: 38645201 Free PMC article. Preprint.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01NS077402/NS/NINDS NIH HHS/United States
- R01 NS086810/NS/NINDS NIH HHS/United States
- R01 GM097455/GM/NIGMS NIH HHS/United States
- R01 NS085207/NS/NINDS NIH HHS/United States
- R01NS050557/NS/NINDS NIH HHS/United States
- RC2 NS070342/NS/NINDS NIH HHS/United States
- Z01 NS002976/Intramural NIH HHS/United States
- CAPMC/ CIHR/Canada
- R21 NS074121/NS/NINDS NIH HHS/United States
- R01ES20395/ES/NIEHS NIH HHS/United States
- Z01-AG000949-02/AG/NIA NIH HHS/United States
- R01AG026251/AG/NIA NIH HHS/United States
- P01 NS084974/NS/NINDS NIH HHS/United States
- R21NS074121/NS/NINDS NIH HHS/United States
- R21NS084528/NS/NINDS NIH HHS/United States
- R21 NS079807/NS/NINDS NIH HHS/United States
- R01GM097455/GM/NIGMS NIH HHS/United States
- R01 NS063964/NS/NINDS NIH HHS/United States
- R01NS063964/NS/NINDS NIH HHS/United States
- R01 NS088689/NS/NINDS NIH HHS/United States
- Z01 AG000949/Intramural NIH HHS/United States
- R01NS088689/NS/NINDS NIH HHS/United States
- R21NS079807/NS/NINDS NIH HHS/United States
- R21 NS084528/NS/NINDS NIH HHS/United States
- RC2-NS070-342/NS/NINDS NIH HHS/United States
- P01NS084974/NS/NINDS NIH HHS/United States
- R01 ES020395/ES/NIEHS NIH HHS/United States
- R01 AG026251/AG/NIA NIH HHS/United States
- R01 NS077402/NS/NINDS NIH HHS/United States
- R01 NS050557/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous